Skip to main content

Table 1 Patient characteristics

From: A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy

  PDS DLS NACT P
n = 85 n = 38 n = 58
Age, mean (range) 55.8 (29–79) 50.8 (27–69) 59.7 (38–79) <0.001
 >75 5 (5.9%) 0 (0.0%) 5 (8.6%)
ASA score
 1 16 (18.8%) 13 (34.2%) 6 (10.3%) <0.001
 2 44 (51.8%) 22 (57.9%) 26 (44.8%)
 3 24 (28.2%) 0 (0.0%) 26 (44.8%)
BMI [IQR] 23.8 [20.9; 25.2] 24.1 [21.1; 25.4] 22.5 [20.6; 24.1] 0.236
CA125, U/mL (range) 1829.4 (44–22,743) 2191.7 (75–13,637) 3828.7 (102–17,094) 0.005
Stage
 IIIC 51 (60%) 31 (81.6%) 11 (19.0%) <0.001
 IV 34 (40%) 7 (18.4%) 47 (81.0%)
Grade
 1 5 (5.9%) 2 (5.3%) 3 (5.2%) 0.708
 2 28 (32.9%) 8 (21.1%) 11 (19.0%)
 3 45 (52.9%) 26 (68.4%) 39 (67.2%)
  1. Unless indicated otherwise, data are presented as n (%)
  2. PDS, primary debulking surgery; DLS, diagnostic laparoscopic surgery; NACT, neoadjuvant chemotherapy; ASA, American Society of Anesthesiologists physical status classification system; BMI, body mass index; IQR, interquartile range; CA 125, carbohydrate antigen 125